tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports

Oncolytics Biotech (ONCY) Stock News & Sentiment

Compare
1,413 Followers
Oncolytics Biotech Bolsters Late-Stage Cancer Push With New Strategy and Biostatistics Leaders
Premium
Company Announcements
Oncolytics Biotech Bolsters Late-Stage Cancer Push With New Strategy and Biostatistics Leaders
1h ago
ONCY
Advancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
Premium
Ratings
Advancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
23h ago
ONCY
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
Premium
Company Announcements
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
2d ago
ONCY
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
Premium
Company Announcements
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
5d ago
ONCY
Oncolytics Biotech Moves to Extend Pelareorep Patent Runway Beyond 2044
Premium
Company Announcements
Oncolytics Biotech Moves to Extend Pelareorep Patent Runway Beyond 2044
6d ago
ONCY
Oncolytics Biotech Adds Leading GI Oncologists to Advisory Board as It Prepares Pivotal Pelareorep Trials
Premium
Company Announcements
Oncolytics Biotech Adds Leading GI Oncologists to Advisory Board as It Prepares Pivotal Pelareorep Trials
7d ago
6K
ONCY
Promising Potential of Oncolytics Biotech’s Pelareorep in KRAS-Mutant MSS Colorectal Cancer Drives Buy Rating
Premium
Ratings
Promising Potential of Oncolytics Biotech’s Pelareorep in KRAS-Mutant MSS Colorectal Cancer Drives Buy Rating
28d ago
ONCY
More ONCY News >

ONCY News on the Web

Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
TipRanks News
Neutral
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
TipRanks News
Neutral
Lake Street Remains a Buy on Oncolytics Biotech (ONCY)
TipRanks News
Neutral
Why Oncolytics Biotech Inc.’s (ONCY) Stock Is Down 5.19%
AAII
Neutral
Why Oncolytics Biotech Inc.’s (ONCY) Stock Is Up 5.72%
AAII
Neutral
Why Oncolytics Biotech Inc.’s (ONCY) Stock Is Down 5.39%
AAII
Neutral
Lake Street Remains a Buy on Oncolytics Biotech (ONCY)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ONCY
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ONCY’s Media Buzz Sentiment?
4 articles about ONCY were published this week. In an average week, 1.75 articles are published.
    What is ONCY’s weekly average amount of articles?
    In an average week, 1.75 articles about ONCY are published.
      What is ONCY’s News Sentiment?
      50% of articles about ONCY were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        KRYSKrystal Biotech
        RVMDRevolution Medicines
        RPRXRoyalty Pharma
        NYXHNyxoah
        BCTBriaCell Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week